RMD ResMed
Permanent stock page ↗Health Care · S&P 500
Next earnings: Thu 28 Jan 2027 · estimated
What 19 analyst firms say about ResMed: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
16 rated views · 19 analyst/firm records · 19 firms
Radar score
- S&P 500 · Top Picks · 6MBelow the Radar threshold of 8020
- S&P 500 · Safest consensus · 6MBelow the Radar threshold of 8034
Recent analyst activity · last 90 days
Our tracked history has 13 reports on RMD from 9 analyst firms in the last 90 days (20 firms in the past year).
Comparing each firm's latest target with its previous one: 5 raised their price target and 1 has its first observed target in the past year.
Ratings, latest available report against the previous one: 0 upgrades and 1 downgrade.
Latest observed target change: Citigroup raised its target from $235.00 (set 13 Jul 2026) to $270.00 on 30 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Baird | David Rescott | ConflictConflicting reports · excluded | 7 Aug 2026 | Conflicting reports · excluded |
| Canaccord Genuity | Shane Storey | Buy | 22 Jul 2026 | — |
| Citigroup | Laura Sutcliffe | Hold | 30 Oct 2026 | 270.00 USD |
| Goldman Sachs | Davinthra Thillainathan | Buy | 1 Jul 2026 | — |
| Jefferies | Matthew C Taylor | Hold | 7 Aug 2026 | Conflicting reports · excluded |
| JPMorgan | David Low | Buy | 15 Apr 2026 | — |
| KeyBanc Capital Markets | Brett Fishbin | Buy | 30 Oct 2026 | 277.00 USD |
| Mizuho | Anthony Petrone | — | 30 Oct 2026 | 270.00 USD |
| Morgan Stanley | David Bailey | Hold | 17 Jun 2026 | 230.00 USD |
| Needham | Michael Matson | Hold | 30 Oct 2026 | — |
| Piper Sandler | Adam Maeder | Hold | 7 Aug 2026 | 225.00 USD |
| RBC Capital Markets | Craig Wong-Pan | Buy | 30 Oct 2026 | 288.00 USD |
| Redburn | Jackson Philips | Hold | 19 Aug 2026 | 230.00 USD |
| Stifel | Jonathan Block | Hold | 30 Jan 2026 | 265.00 USD |
| UBS | Marcus Curley | Buy | 7 Aug 2026 | Conflicting reports · excluded |
| Weiss Ratings | Unnamed analyst | — | 8 Oct 2026 | — |
| Wells Fargo | Nathan Treybeck | Hold | 30 Oct 2026 | 250.00 USD |
| Wolfe Research | Mike Polark | Sell | 7 Aug 2026 | Conflicting reports · excluded |
| Data feed RESEARCH | Research Team | Hold | 15 May 2026 | 247.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 04:01 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.